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Abstract
The purpose was to investigate the prevalence rate, characteristics and related factors of breast cancer among women in
Eastern China. A total of 122,058 female subjects completed the study, with 320 confirmed cases of breast cancer (crude
prevalence: 262.5/100,000; standardized prevalence: 207.7/100,000). Among all of the identified breast cancer cases, 91.6%
were diagnosed after the age of 35 and 60.0% were diagnosed before menopause. The odds ratios (95% confidence
interval) of those breast cancer risk factors as selected through multivariate logistic regression were as follows: 5.438 (1.553–
19.004) for family history of breast cancer, 3.556 (1.880–6.728) for high behavior intervention score, 3.556 (0.904–13.994) for
history of diabetes, 3.357 (1.131–9.969) for history of benign breast tumors, 2.196 (1.355–3.556) for poor overall life
satisfaction, 1.826 (0.995–3.350) for premenopause of breast cancer, 1.528 (1.083–2.155) for high BMI index, 1.500 (0.920–
2.446) for poor financial status, 1.497 (1.014–2.211) for multiple miscarriages/abortions, and 1.231 (0.972–1.559) for
infrequent consumption of garlic (frequent garlic consumption is a protective factor). There were significantly more cases of
breast cancer diagnosed prior to menopause than after menopause, and most of the patients were diagnosed after the age
of 35. These findings suggest that attention should be focused on the incidence of breast cancer among premenopausal
women older than 35.
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Introduction
Breast cancer is one of the most common malignancies in
women worldwide and is the leading cancer-related cause of death
in women [1,2]. Since the 1970s, there have been no population-
based large-scale surveys or nationwide disease survey except some
hospital-based study for breast cancer in China. Some regional
surveys have indicated that the incidence of breast cancer is rising
in Chinese women [3]. However, most of these studies were
focused on economically–developed, large cities, such as Beijing,
Shanghai and Tianjin, despite nearly 70% of Chinese population
being located in rural areas. Substantial international and
domestic research has focused on the influencing factors associated
with breast cancer. However, these studies were largely based on
clinical cases with limitations due to small sample size, different
ethnic groups within the target population and differences in
regional social-economic conditions and customs, which resulted
in inconsistent conclusions. In general, the causes of breast cancer
are still not fully understood; therefore, obtaining relevant risk
factors for breast cancer through a population-based case-control
study can contribute to the effective prevention and intervention of
breast cancer among the population and make significant
contributions to public health. In this study, a cross-sectional
survey was performed in Eastern China between July 15 and
September 15, 2008, to better understand the prevalence rate,
characteristics and risk factors for breast cancer in Chinese
women.
Methods
Study Subjects
Random samples were obtained through multi-stage stratified
cluster sampling. The target population included 25- to 70-year-
old females of the Han ethnic group with over two years of local
residence and at least six months of local residence at the time of
survey. Long-term migrant workers, who left hometown for work,
were excluded from this study. The provinces in Eastern China
where the Han ethnic group mainly resides, including Shandong,
Jiangsu, Hebei and Tianjin, were selected as the survey provinces.
Subsequently, counties or regions were randomly selected from
each province. Finally, villages or communities were randomly
selected from the sampled counties or regions, and women who
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e37784met the study requirements were selected for the survey. The
required sample size of 86,667 subjects was estimated using a
Poisson distribution with 300 cases expected and an estimated
prevalence rate of 200/100,000 [4–6]. Because cluster sampling
was employed, the actual sample size needed was considered to be
1.5 times of the required sample size; thus, 130,000 subjects were
needed for the survey. The details of the sampling procedure are
shown in Figure 1.
Those breast cancer patients (123 cases) who were diagnosed
within two years of the survey were selected as the breast cancer
group, and the nearest neighbors of the patients, who were healthy
and had no blood relationship with the patients, were selected as
the control group in accordance with the 1:3 principle. The
matching factors were age (same age 62 years) and location
(neighbor or co-worker in the same region).
Questionnaire Content
Data were collected through in-person interviews based on a
self-designed structured questionnaire. The questionnaire included
six aspects gathered from patient interviews: (i) demographic
characteristics: age, marital status, education, occupation, house-
hold income, height, body weight, financial status and social status;
(ii) female physiological and reproductive factors: age at menarche,
age at menopause, menstrual cycle history, childbearing history,
breastfeeding methods, abortions or miscarriage, contraceptive
methods and use of contraceptive medicine; (iii) medical and
family history: primarily breast-related diseases and family history
of breast cancer; (iv) dietary habits: frequency of the intake of
various types of food; (v) lifestyle habits: smoking (including passive
smoking), alcohol intake, tea intake, physical exercise and mental
and psychological conditions (the items under psychological status
were summed to calculate the overall life satisfaction and current
life satisfaction scores); (vi) breast-cancer-related knowledge: risk
factors for breast cancer and early signs and symptoms of disease
(the cumulative scores of these relevant items were counted as the
related knowledge score and behavioral prevention score). The last
component of the questionnaire was gathered from the clinical
breast exam and included the results from visual examination,
palpation and related diagnostic tests.
With the exception of the basic demographic information, all
questions had multiple-choice responses and attempts were made
to quantify or categorize the answer choices (e.g., yes/no or 1/2/
3/4). For all of the variables covered by the questionnaire, the
answers were defined by strict criteria (See Table 1) [4].
Figure 1. Random samples were obtained through multi-stage stratified cluster sampling. Shandong, Jiangsu, Hebei and Tianjin were
selected as the sampling provinces because these provinces were manliy resident areas of Han ethnic group. And counties/regions and villages/
communities were subsequently randomly selected from each province. Totally, 124,758 female, 1.5 times of the required sample size, were selected
as study population. And the details of sampling information were shown in this figure.
doi:10.1371/journal.pone.0037784.g001
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This study was approved by the ethics committees at the
collaborating institutions in each region and informed consent was
obtained from all the study subjects. Investigators and physicians
were recruited in each survey region before the implementation of
this study. To ensure objectivity and authenticity, all participating
investigators and physicians performing physical examinations
received strict and standardized professional training before the
implementation of the project. The main on-site data collection
procedure is shown in Figure 2. The clinical breast examination
consisted of two components: a basic breast examination
(including visual examination and palpation) and standardized
auxiliary diagnostic test, such as an ultrasound and/or mammo-
gram, for survey subjects with suspected disease on physical exam
(the detailed criteria for suspected positive physical signs of disease
are shown in Table 2). The subjects diagnosed with breast cancer
on biopsy were enrolled into the breast cancer group, while
healthy subjects, as confirmed by clinical physical examination and
diagnostic imaging, were included in the control group. A total of
2,613 subjects had an abnormal breast examination, all of who
received an ultrasound and mammogram. Among these subjects,
58 had abnormalities detected with diagnostic imaging, and 262
reported being previously diagnosed with breast cancer.
To test the reliability of the clinical breast examination
performed for this study, 145 subjects were randomly selected to
form a normal control group. All the subjects in this control group
were randomly selected from the survey subjects with a normal
physical exam. This group then received an ultrasound and
mammogram. Two radiologists interpreted the ultrasound and
mammograms based on Breast Imaging-Reporting and Data
System (BI-RADS) classification [5]. After group consultation with
the specialists, 123 subjects (84.83% of 145) were classified as BI-
RADS 1, 14 (9.66%) as BI-RADS 2 and 8 (5.52%) as BI-RADS 3,
which suggested that the physical examination results in this study
were reliable.
Quality Control
All interviews and clinical examinations in this survey were
completed within two months, and all survey subjects were
selected strictly according to the random sampling method.
During the survey process, a supervisor in each region oversaw
the surveyors and sampled their work for inspection. Further, 10%
of the questionnaires completed at the end of each day were
randomly sampled to inspect for their completeness, accuracy and
standardization. After the quality assessment was completed, all
identified errors and missed survey items were promptly corrected.
Table 1. Explanation of terms used in the questionnaire.
Terms Explanation
Household member The actual household members who are residing and living together.
Employment The recent employment or the longest employment in the past year.
Body mass index (BMI) The body height, weight, waist circumference, and hip circumference were measured on site, and then BMI was calculated.
Times of pregnancy and delivery All the pregnancy times, regardless of the outcomes including live birth, stillbirth, spontaneous abortions, and artificial
abortion.
History of breast-feeding The actual breast-feeding duration (unit: months) was recorded.
Menstrual history Based on NCCN 2008 definition.
Relevant diseases Only formally confirmed diseases were included.
Smoking At least one cigarette per day for at least one year.
Second-hand smoke Whether there is any person who live or work with you smokes.
Insomnia Difficulty falling asleep or remaining asleep, poor sleep quality, and remarkably reduced sleep time, which is harmful for
health and affects the normal daily activities.
Wake up early and stay up late Wake up 2 hours earlier in the morning or stay up 2 hours later at night when compared with the normal sleep-wake
schedule.
Diets and alcohol Based on the consumption frequency, the diets and alcohol was measured suing 1/2/3/4 scale.
Life satisfaction The overall life satisfaction (current, future, and past) and the current life satisfaction (on housing, income, health,
marriage, medical care, and neighbors) were measured using 1/2/3/4/5 scale.
Hormone replacement The hormone refers to the natural estrogen (estradiol, estrone, and estriol) and synthetic estrogens.
Drug history Medication hsitory was recorded once a drug was used (unit: months).
doi:10.1371/journal.pone.0037784.t001
Table 2. Criteria for suspected positive physical signs in breast exam.
Physical signs
1 Palpation of irregular mass
2 Nipple discharge (including bloody, yellow-green and colorless discharge)
3 Nipple retraction and changes in surrounding skin (including peau d’orange, dimple sign, erythema and edema)
4 Swollen or hard axillary lymph nodes
doi:10.1371/journal.pone.0037784.t002
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interviewer would collect the missing information from the original
survey site the next day. Finally, after the completion of survey,
sampled re-screening was performed for each survey site, and the
results showed a consistency of 92.19%. Clinical breast examina-
tions were performed independently on each survey subject by two
physicians who had received standardized training and had over
three years of working experience in a breast surgery department.
When the examination results from the two physicians were
inconsistent, the supervisor at the survey site would discuss the case
Figure 2. The investigation involved face-to-face interviews based on self-designed structured questionnaires and subsequente
clinical breast examinations. And subjects with suspected positive physical signs would receive further ultrasonic and X-ray examinations and
possible biopsies. After the above proceeds, breast cancer cases were identified. In total, 124,758 were collected in the study, and because of
information loss, 122,058 cases were included in the final analysis.
doi:10.1371/journal.pone.0037784.g002
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training was provided to the personnel who performed data entry
and double data entry was performed.
Statistical Analyses
The database was established using the software EpiData3.1.
Statistical methods, including t-test, x
2 test, and univariate and
multivariate conditional logistic regression analyses, were used to
identify the risk factors for breast cancer. The odds ratios (OR)
with 95% confidence intervals were also calculated. All data
analyses were performed using SPSS16.0.
Results
In this survey, 147,538 women were initially selected, and of
these women, 124,758 were reached to complete the survey, giving
a rate of loss at 15.44%. Of the 124,758 women surveyed, 122,058
were included in the final analysis because 2,700 questionnaires
had to be excluded due to incomplete information.
The average age of the 122,058 surveyed women was 44.2 years
old (SD=11.6). There were 19,741 subjects (16.2%; M=42.8
years old) from Hebei Province, 20,921 subjects (17.1%; M=46.3
years old) from Jiangsu Province, 61,104 subjects (50.1%;
M=43.50 years old) from Shandong Province and 20,292 subjects
(16.6%; M=45.6 years old) were from Tianjin. A total of 88,362
surveyed subjects were from rural areas and 33,696 were from
urban areas. The ratio of urban to rural population was 0.38:0.62,
which is similar to the data from the census in China in 2000
(0.36:0.64). Among the surveyed population, 85,752 were
premenopausal (70.3%) and 36,306 (29.7%) were postmenopausal.
The average age at menopause in the postmenopausal subjects was
48.8 years old (SD=4.11). The average age at menarche in all
surveyed women was 15.4 years old (SD=2.0). There were
118,623 (97.2%) subjects who had at least one child before the
survey and 95,434 (78.6% of 118,623) who had breast-fed for at
least 12 months.
This study found 320 cases of breast cancer, with a prevalence
rate of 262.5/100,000 and a standardized prevalence rate of
207.7/100,000 (adjusted based on the 2007 China’s National
Population Age Structure). Among these breast cancer cases, 58
(18.12%) were newly identified, 265 (82.81%) were diagnosed
within the last 10 years and 55 (17.19%) were diagnosed more
than 10 years ago. The mean age of the patients with breast cancer
was 47.8 years old (SD=9.3),293(91.6%) were diagnosed after the
age of 35 and 27(8.4%) were diagnosed before the age of 35, This
group included 122 premenopausal patients (38.12%) and 198
postmenopausal patients (61.88%). The average age at diagnosis
Figure 3. Detailed distributions of the breast cancer cases from the four survey areas by age are shown in this figure. Overall, breast
cancer cases identified in this study were primarily diagnosed in the 40–45 and 45–50 year age groups.
doi:10.1371/journal.pone.0037784.g003
Table 3. Pathological information on cases of breast cancer.
Number of cases (n) Percent (%)
Pathological type
Invasive cancer 179 81
Non-invasive cancer 20 9.05
Unknown 22 9.95
OR-status(oestrogen receptor)
Positive 76 34.3
Negative 20 9.05
Unknown 125 56.6
Lymph node status
Positive (1–4) 49 22.2
Positive (.4) 23 10.4
Negative 94 42.5
Unknown 55 24.9
Tumour size
,2c m 22 9.95
2c m – 5c m 97 43.9
.5c m 19 8.6
Unknown 83 37.6
Clinical stage
0 18 8.14
I 21 9.5
II 92 41.6
III 24 10.9
IV 10 . 5
Unknown 65 29.4
doi:10.1371/journal.pone.0037784.t003
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premenopausal, while 128(40%) were postmenopausal. The
average age of menopause for the postmenopausal breast cancer
patients was 48.4 years old (SD=4.5). The average menarche age
of the breast cancer patients was 15.8 years old (SD=2.2). Among
the 320 patients, 278 (88.3%) had breast-fed for at least 12
months. Pathologic diagnosis was performed in 221 (69%) cases,
with 81%(179/221) of these patients diagnosed with invasive
breast cancer. The detailed pathology results are shown in Table 3.
The crude prevalence rate of breast cancer varied in different
regions: 420.5/100,000 (366.9/100,000) in Hebei Province,
252.1/100,000 (205.5/100,000) in Shandong Province, 224.7/
100,000 (151.9/100,000) in Jiangsu Province and 178.7/100,000
(133.5/100,000) in Tianjin. Standardized prevalence rates based
on the age data of 2007 China’s national population is shown in
parentheses. Detailed distributions of the breast cancer cases from
the four survey areas are shown in Figure 3. Overall, the
prevalence of breast cancer varied with significantly over time
Figure 4. The prevalence of breast cancer varied with significantly over time: among the 320 breast cancer cases, 179 (55.94%)
were diagnosed within the past three years, including 78 cases within the last year, 45 cases within the last two years and 56 cases
within the last three years.
doi:10.1371/journal.pone.0037784.g004
Table 4. Related factors of demographic variables of breast cancer.
Variables Number of cases participants The prevalent rate (1/100,000) x
2 p
Location
Urban 84 33696 249.3 0.295 0.287
Rural 236 88362 267.1
Education
Elementary 154 48570 317.1 15.859 0.001
Middle 96 42483 226.0
High 55 19186 286.7
College or above 15 11639 128.9
Personal annual income (RMB)
,10000 223 77858 286.4 7.859 0.005
.=10000 68 34907 194.8
Marriage
No 1 1437 69.6 2.062 0.151
Yes 319 120621 264.5
Body Mass Index
,25 186 91488 203.3 55.667 0.000
252 111 27075 410.0
.=30 23 3497 657.7
Family history of breast cancer
Yes 21 1120 1875.0 112.400 0.000
No 299 120938 247.2
doi:10.1371/journal.pone.0037784.t004
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cases, 179 (55.94%) were diagnosed within the past three years (see
Figure 4), including 78 cases within the last year, 45 cases within
the last two years and 56 cases within the last three years. The
cases diagnosed within the last three years accounted for 47.0% of
cases (39/83) in Hebei Province, 59.7% (92/154) in Shandong
Province, 57.5% (27/47) in Jiangsu Province and 58.4% (21/36)
in Tianjin.
The demographic characteristics for the breast cancer patients
are shown in Table 4, indicating a statistically significant difference
in the breast cancer prevalence among different population
groups. Differences were seen in various levels of education
(p=0.001), individual annual income (p=0.005), BMI-body mass
index (p,0.001) and breast cancer family history (p,0.001).
There were statistically significant differences in the prevalence of
breast cancer among some of the variables representing female
physiological characteristics (Table 5), including menstrual cycle
regularity, number of childbirths, number of abortions/miscar-
riages, menopausal status, history of benign breast disease,
mammary gland hyperplasia, nipple discharge, presence of an
accessory breast and nipple retraction. Those physiologic variables
not associated with significant differences in breast cancer
prevalence included the age at menarche, history of dysmenorrhea
and history of oral contraceptive use. Those chronic diseases
associated with a significant difference in the distribution of breast
cancer cases (Table 6) included cervical cancer, ovarian cysts,
diabetes, hypertension and coronary heart disease.
The cases diagnosed within the past two years (n=123) were
used for the 1:3 matched analysis of factors affecting breast cancer.
The average age of the patient group with diagnosed disease was
49.9269.36 years old, and the average age of the control group
was 49.9569.49 years old; there was no significant difference
between the two groups (p=0.851). In the patient group, 96 cases
(78.0%) were from rural areas compared to 272 cases (73.7%) in
the control group; there was no statistically significant difference
between the two groups (p=0.337). Other basic demographic
characteristics of the two groups are shown in Table 7.
The results of the univariate analysis at the level of a=0.20
indicated that the breast-cancer-related factors included education
level, household annual income, body mass index (BMI), breast
cancer family history of primary or secondary relatives, number of
miscarriages/abortions, regularity of menstruation, menopausal
status at diagnosis, history of benign breast tumor, nipple
discharge, soy product consumption, garlic product consumption,
insomnia, current life satisfaction, overall life satisfaction, financial
status, social status, the behavioral prevention score and the
related knowledge score. Multivariate logistic regression analysis
(a=0.10) identified nine variables related to breast cancer: BMI,
menopausal status at diagnosis, history of benign breast tumor,
family history of breast cancer, history of diabetes, number of
miscarriages/abortions, overall life satisfaction, garlic product
consumption, financial status and the behavioral prevention score
(Table 8 & 9).
Discussion
This survey is the first large-scale, cross-province epidemiolog-
ical investigation in China since the 1970s. A total of 320 cases of
breast cancer were identified in this survey. The cases diagnosed
within the past three years accounted for 67.6% (179/265) of those
cases diagnosed within the past ten years and for 55.9% (179/320)
of all cases. Further investigation found that the breast cancer
cases identified in this study were primarily diagnosed in the 40–45
and 45–50 year age groups (21.6% and 30.3%, respectively),
suggesting that the peak of breast cancer incidence in China may
be 15–20 years before the peak incidence in Western countries [6].
There were 192 premenopausal cases, accounting for 60% of the
identified breast cancer cases, and 128 postmenopausal cases,
accounting for 40%. The majority of breast cancer cases are
premenopausal in China, which is different from European and
American countries, where the majority of breast cancer cases are
postmenopausal [7]. This result is consistent with the finding of Li
et al, which showed that the premenopausal cases accounted for
62.9% [8]. In our study, both the univariate and multivariate
analyses showed that the menopausal status at diagnosis was
associated with breast cancer and premenopause was a risk factor
of breast cancer (OR: 1.826). In fact, in our study, the
premenopausal women accounted for 70.3% among all the
surveyed individuals and 60% in the case group, suggesting that
more attention should be paid to the premenopausal women.
Table 5. Related factor of physiological variables to breast
cancer.
Variables Cases Participants
The
prevalent
rate x
2 P
Age of menarche
7–11 3 867 346.0 1.782 0.619
12–13 43 19395 221.7
14 or more 274 101744 269.3
Missing value 0 52 0
Regularity of menstruation
Yes 291 114514 254.1 4.959 0.032
No 29 7544 384.4
Parity
,2 118 70719 166.9 58.414 0.000
.=2 202 51339 393.5
Times of misbirth
0 199 91433 217.6 e 0.000
1 75 20632 363.5
2 34 7398 459.6
.2 12 2427 494.4
Dysmenorrheal
No 253 100313 252.2 2.136 0.144
Yes 67 21745 308.1
Menopause or stop
No 122 85755 142.3 158.5 0.000
Yes 198 36303 545.4
Oral contraceptive
Yes 18 5580 322.6 1.180 0.554
No 298 114061 261.3
Missing value 4 2101 190.4
Benign of breast gland tumor
Yes 27 854 3161.6 276.6 0.000
No 293 121204 241.7
Hyperplasia of galactophore
Yes 31 7487 414.0 7.037 0.008
No 289 114571 252.2
doi:10.1371/journal.pone.0037784.t005
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the age of 35 and 8.4% were diagnosed before the age of 35, which
emphasizes the importance of regular breast examinations for
Chinese women over the age of 35 or additional interventions to
preemptively prevent breast cancer. On the other hand, this study
also indicates the possibility that the age of onset for breast cancer
in Chinese women is declining, suggesting that breast cancer
prevention should not be neglected for women younger than 35.
Although a large number of studies have been reported on the
factors affecting breast cancer in China by both domestic and
international researchers, previous results were inconsistent due to
the lack of a population-based study of risk factors [8–10]. In this
study, we found that the average age of menopause for Chinese
women was 48.8 years old and that the average age of menarche
was 15.4 years old. Only univariate logistic analysis showed that
irregular menstruation could increase the risk of breast cancer
(OR: 1.743), which was consistent with the results of prospective
studies by other international researchers [11–13]. The age of
menarche of Chinese women is two to three years later than the
age of menarche in women from the US and European countries.
The characteristics of late menarche, early menopause and short
menstrual cycles in Chinese women may partially explain the low
incidence of breast cancer in China. Childbirth, especially with
full-term pregnancy and associated breastfeeding [14], has been
generally considered an important protective factor against breast
cancer. Multiple childbirths could also reduce the risk of breast
cancer [12,15]. Both univariate and multivariate logistic regression
analyses showed a statistically significant correlation between
miscarriage/abortion and breast cancer, and the ORs were 1.644
and 1.497, respectively. Internationally, there is no conclusive
evidence on the relationship between miscarriage/abortion and
breast cancer. Some of the studies have supported the correlation
between abortion and breast cancer [16–18], while others have
indicated no apparent relationship [19–21]. Also in this study,
there were no relationships identified between breast cancer and
some factors that have been previously shown to be related to
breast cancer, such as age at menarche, menstrual years,
menopause, age at first childbearing, full-term pregnancy and
breastfeeding. It may be explained by the following reasons:
Traditionally, Chinese women are requested for childbirth and
breastfeeding, and they enjoy taking these responsibilities. In our
study, 97.2% of the subjects had given birth to at least one child
and 78.6% had breastfed for at least 12 months; few women have
never given birth or breastfed. Chinese couples were permitted
one or two children only since the implementation of birth control
policies beginning in 1970s. Therefore, it is hard to explore the
relationship between multiple deliveries and breast cancer. Neither
univariate nor multivariate analysis showed any statistical signif-
icance when compared with other factors. Wang et al. [22]
conducted a case-control study on breast cancer risk factors in six
cities in China, including Beijing, Tianjin and Shanghai, which
also showed inconsistent conclusions.
Breast cancer displays an apparent familial tendency. Univar-
iate analyses were used to study the primary and secondary family
Table 6. Association between chronic diseases and breast cancer.
variables Cases Participants
The prevalent
rate (/1 million) x
2 P
Cervix Cancer
Yes 3 274 1094.9 7.283 0.007
No 317 121784 260.3
Ovary Cancer
Yes 0 43 0 0.113 0.737
No 320 122015 262.3
Ovary cyst
Yes 9 1488 604.8 6.764 0.009
No 311 120570 257.9
Diabetes mellitus
Yes 16 1505 1063.1 37.385 0.000
No 304 120553 252.2
Hypertension
Yes 42 7467 562.5 27.431 0.000
No 278 114591 242.6
Coronary heart disease
Yes 9 1701 529.1 4.701 0.030
No 311 120357 258.4
Nephritis
Yes 2 221 905.0 3.499 0.061
No 318 121837 261.0
Mental disorders
Yes 1 148 675.7 0.969 0.325
No 319 121910 261.7
doi:10.1371/journal.pone.0037784.t006
Breast Cancer in Eastern China
PLoS ONE | www.plosone.org 8 June 2012 | Volume 7 | Issue 6 | e37784history of breast cancer, as well as the unclassified family history of
breast cancer. The results demonstrated statistical correlations
between a family history of breast cancer and the incidence of
breast cancer. The unclassified family history of breast cancer was
selected for the multivariate logistic analysis, and the results also
indicated that family history of breast cancer is a risk factor for
breast cancer (OR: 5.438), which is consistent with the results from
other international studies [23,24]. Patients with benign breast
diseases have a higher risk of breast cancer than healthy
individuals [25,26]. The results from the present study also
indicated a close correlation between the history of benign breast
tumors and breast cancer (OR: 3.357), suggesting that a history of
benign breast diseases is an important risk factor for breast cancer
in women. These results are consistent with results from the cohort
studies by Fang et al. [27] and Colep [28].
This study discovered a correlation between history of diabetes
and breast cancer (OR: 3.556). Previous studies indicated that type
2 diabetes is a risk factor for breast cancer [29]. The results from
the meta-analysis showed diabetes and the risk of breast cancer
revealed that diabetes increased the risk of breast cancer by 20%
[30]. With the exception of the case-control study by Liao et al.
[31], which indicated that diabetes was a risk factor for breast
cancer, no other reports were found on this relationship between
diabetes and breast cancer in Asian women. Diabetes, especially
type 2 diabetes, is closely related to obesity. In China, 30% of type
2 diabetes patients are obese. Diabetes together with obesity may
increase the risk of breast cancer [32].
This study found that a high BMI had a statistically significant
correlation with breast cancer (OR: 1.528), which is consistent
with the results from the previous studies [33,34]. With the
changes in lifestyle and improvements in living conditions in
China, overweight and obese people account for a large
proportion of the Chinese population. The epidemiological survey
of diabetes conducted in 2008 indicated that the prevalence of
diabetes was 11.6% in urban populations and 10.6% in women.
One study reported that 36.97% of the female population was
overweight and that 15.39% was obese [35]. The association
between the increasing incidence of breast cancer and the rapid
growth of the diabetic and obese population requires further in-
depth investigation. A healthy lifestyle and preventing obesity and
diabetes are important steps in the prevention of breast cancer,
especially in China, given the rapid increase in the overweight and
obese population [36].
Table 7. The basic demographic information of the patient
and control groups.
Variables Case N (%) Control N (%) x
2(df) p
Residence
Urban 27 (22.0) 97 (26.3) 0.920 (1) 0.337
Rural 96 (78.0) 272 (73.7)
Education
Elementary or low 58 (47.2) 192 (52.0) 4.696 (3) 0.195
Middle 36 (29.3) 86 (23.3)
High 24 (19.5) 60 (16.3)
College 5 (4.0) 31 (8.4)
Economic statues
Very good(1) 4 (3.3) 10 (2.7) 7.858 (3) 0.049
Good(2) 15 (12.2) 76 (20.6)
Normal(3) 92 (74.8) 266 (72.1)
Poor(4) 12 (9.8) 17 (4.6)
Social statues
Very good(1) 4 (3.3) 11 (3.0) 9.607 (3) 0.022
Good(2) 18 (14.6) 77 (20.9)
Normal(3) 93 (75.6) 275 (74.5)
Poor(4) 8 (6.5) 6 (1.6)
Family annual income (RMB)
,15000 69 (56.1) 178 (48.2) 2.279 (1) 0.131
.=15000 54 (43.9) 191 (51.8)
Marriage
Never 5 (4.1) 19 (5.1) 0.234 (1) 0.629
Ever 118 (95.9) 350 (94.9)
Body Mass Index
,24.0 57 (46.3) 206 (55.9) 9.852 (3) 0.020
24.0–28.0 34 (27.6) 111 (30.1)
.=28.0 32 (26.0) 52 (14.1)
Family history of breast cancer
Yes 10 (8.1) 7 (1.9) 10.744 (1) 0.001
No 113 (91.9) 362 (98.1)
doi:10.1371/journal.pone.0037784.t007
Table 8. Multivariate logistic analysis of breast cancer-related factors among women.
Factors Characteristics P OR (95% CI)
Unfavorable Favorable
Benign breast disease history yes no 0.029 3.357 (1.131–9.969)
Diabetes Mellitus yes no 0.069 3.556 (0.904–13.994)
Garlic consumption infrequent frequent 0.084 1.231 (0.972–1.559)
Economic Status low high 0.104 1.500 (0.920–2.446)
Times of miscarriage .=1 0 0.043 1.497 (1.014–2.211)
Family history of breast cancer yes no 0.008 5.438 (1.553–19.004)
Global quality of life satisfaction low high 0.001 2.196 (1.355–3.556)
BMI .=24.0 ,24.0 0.016 1.528 (1.083–2.155)
Menstrual status Premenopausal Postmenopausal 0.052 1.826(0.995–3.350)
Healthy behavioral prevention score high low 0.000 3.556 (1.880–6.728)
doi:10.1371/journal.pone.0037784.t008
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describe the overall life satisfaction and the cumulative score of six
items to assess current life satisfaction. The scores were classified
into two types, high and low scores. High scores indicated low life
satisfaction or dissatisfaction, whereas low scores indicated high life
satisfaction. The results of this study indicated a positive
correlation between low overall life satisfaction (or dissatisfaction)
and breast cancer (OR: 2.196), indicating that psychological
factors may be associated with breast cancer. Therefore,
psychological intervention should be considered in the compre-
hensive prevention of breast cancer in the population.
The present study has its limitations. First, only 25- to 70-year-
old women of the Han ethnic group in Eastern China were
selected as the survey targets; therefore, our study results have
limitations for extrapolation. Second, the cases used for risk factor
analysis were those diagnosed within the past two years. However,
it may introduce prevalence-incidence bias (Neyman bias). Third,
age is considered as an important risk factor for breast cancer;
however, in the present study, we matched the cases according to
both age and region to control for confounding factors. Thus, the
correlation between age and breast cancer risk was not investi-
gated in this study.
In conclusion, these findings suggest that attention should be
focused on the incidence of breast cancer among premenopausal
women older than 35. The incidence of breast cancer is associated
with biological, behavioral and social factors, and comprehensive
measures should be taken to prevent the occurrence of breast
cancer.
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